Accueil
VN

Vigil Neurosciences

1.4K
94
7
4.6(40)

À Propos de l'Entreprise

  • Raison sociale: Vigil Neurosciences
  • Nom international: Vigil Neuroscience, Inc., Watertown, Massachusetts (acquired by Sanofi)
  • Marque / Nom commercial: Vigil Neuroscience
  • Pays d'enregistrement: United States
  • Adresse: Watertown, Massachusetts, United States • Massachusetts
  • Année de création: 2020
Description:

American clinical stage biotechnology company at Watertown in Massachusetts, founded in 2020 to work on microglia and the TREM2 receptor in neurodegenerative disease, listed in New York and bought by Sanofi in 2025. Developed iluzanebart, an antibody against TREM2 for adult onset leukoencephalopathy with axonal spheroids, and a small molecule TREM2 agonist for Alzheimer's disease, with its own discovery research, biomarker and clinical development programmes.

Activités Commerciales

Produits Biopharmaceutiques

FabricantEntreprise en phase de démarrage (start-up)Entreprise de Biotechnologie / Biopharmaceutique

Services d'Organismes de Recherche sous Contrat (CRO)

Organisation de Recherche Clinique (CRO)

Services Biopharmaceutiques

Institut de Recherche
Filtres :
Trier par :

    Aucun commentaire disponible.